Fiorela N Hernandez Tejada, MD
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Adoptive Cell Therapy for pediatric solid tumors
Clinical Interests
Neuroblastoma, Bone and Soft tissue sarcomas
Education & Training
Degree-Granting Education
| 2008 | Universidad Peruana Cayetano Heredia, Lima, PE, MD |
| 2000 | Hiram Bingham The British International School of Lima, Lima, PE, Bilingual Diploma in International Baccalaureate |
Postgraduate Training
| 2016-2018 | Research Fellowship, Advance Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2013-2016 | Clinical Fellowship, Pediatric Hematology-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2011-2013 | Clinical Residency, Pediatrics, Miami Children's Hospital, Miami, Florida |
| 2010-2011 | Clinical Internship, Pediatrics, Miami Children's Hospital, Miami, Texas |
Licenses & Certifications
| 2024 | Tennessee Medical License |
| 2024 | Washington Medical License |
| 2024 | Arizona Medical License |
| 2024 | Mississippi Medical License |
| 2024 | Louisiana Medical License |
| 2024 | Oklahoma Medical License |
| 2024 | Alabama Medical License |
| 2024 | Georgia Medical License |
| 2022 | American Board of Pediatrics |
| 2017 | Florida Medical License |
| 2013 | Texas Medical License |
Experience & Service
Administrative Appointments/Responsibilities
Immunotherapy Team Leader, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Non-Neural Solid Tumor Team Leader, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Extramural Institutional Committee Activities
Member, Scientific Review Committee #3, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Pediatrics M&M Planning Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Pediatric Clinical Practice, The University of Texas MD Anderson Cancer Center, 2020 - Present
Honors & Awards
| 2020 - 2021 | MD Anderson Willie Tichenor Fellow in Sarcoma, UT MD Anderson Cancer Center |
| 2018 | Brigid Leventhal Special Merit Award, Conquer Cancer Foundation ASCO |
| 2015 | Travel Award, Hemostasis and Thrombosis Research Society |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2020. TCR-gene therapy for pediatric solid tumors. Conference. TCR-gene therapy for pediatric solid tumors. Houston, TX, US.
- 2016. ROR1-specific car for neuroblastoma using sleeping beauty-modified T cells. Conference. ROR1-specific car for neuroblastoma using sleeping beauty-modified T cells. Houston, TX, US.
National Presentations
- 2024. Critical need for empowerment and transformation in Practice. Invited. 2024 Hispanic/Latin Women in Medicine conference, Phoenix, US.
- 2018. Pediatric Poster discussion session. Conference. Pediatric Poster discussion session. Chicago, IL, US.
Grant & Contract Support
| Date: | 2020 - 2021 |
| Title: | Targeting Neoantigens in Pediatric Sarcomas |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| Title: | Tumor Antigen Discovery Using Tumor-Infiltrating Lymphocytes |
| Funding Source: | NA |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Galvez-Silva J, Maher OM, Park M, Liu D, Hernandez Tejada FN, Tewari P, Nieto Y. Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 23(8):1276-1281, 2017. e-Pub 2017. PMID: 28435146.
- Graham RM, Hernandez Tejada FN, Puerta N, DeAngulo G, Webster KA, Vanni S. Resveratrol Augments ER Stress and the Cytotoxic Effects of Glycolytic Inhibition in Neuroblastoma by Downregulating Akt in a Mechanism Independent of SIRT1. Experimental and Molecular Medicine 48(2), 2016. e-Pub 2016. PMID: 26891914.
- Tomatis, C, Taramona, C, Rizo-Patrón, E, Hernandez Tejada, FN, Barrón-Rodríguez, P, Piscoya, A, Gonzales, E, Gotuzzo, E, Heudebert, G, Centor, RM, Estrada, CA. Evidence-based medicine training in a resource-poor country, the importance of leveraging personal and institutional relationships. Journal of Evaluation in Clinical Practice 17(4):644-650, 2011. e-Pub 2011. PMID: 21276140.
Review Articles
- Gibson A, Hernandez C, Hernandez Tejada FN, Kawedia J, Rytting ME, Cuglievan B. Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia. Pediatric Drugs 23(5):457-463, 2021. e-Pub 2021. PMID: 34351604.
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall DC, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler KL, Li S, Di Nardo M, Chi TL, Gulbis A, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan C, Lehmann L, Hingorani S, Angelo J, Swinford R, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta JJ, Choi SW, Bajwa R, Dailey Garnes NM, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall E, Corbacioglu S, Mahadeo KM. Diagnosis, Grading and Management of Toxicities from Immunotherapies in Children, Adolescents and Young Adults with Cancer. Nature Reviews Clinical Oncology 18(7):435-453, 2021. e-Pub 2021. PMID: 33608690.
- Hernandez Tejada FN, Zamudio A, Marques-Piubelli ML, Cuglievan B, Harrison DJ. Advances in the Management of Pediatric Sarcomas. Current Oncology Reports 23(1), 2021. e-Pub 2021. PMID: 33196879.
- Hernandez Tejada FN, Galvez Silva JR, Zweidler-McKay PA. The challenge of targeting notch in hematologic malignancies. Front Pediatr 2:54, 2014. e-Pub 2014. PMID: 24959528.
Other Articles
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall DC, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler KL, Li S, Di Nardo M, Chi TL, Gulbis A, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald, JC, Tewari P, Petropoulos D, Gill JB, Duncan C, Lehmann L, Hingorani S, Angelo J, Swinford R, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta JJ, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu, SS, Shpall E, Corbacioglu S, Mahadeo KM Author Correction. Nature Reviews Clinical Oncology 18(7):468, 2021. PMID: 33731864.
Abstracts
- Olivares S, Hernandez F, Zhang W, Zhang Z, Gorlick R, Singh H. Effective targeting of osteosarcoma by ex vivo expanded TCR gd T cells, 2024. e-Pub 2024.
- Hernandez F, Jawed J, Olivares S, Mahadeo K, Singh H. Gamma Delta T Cells for Acute Myeloid Leukemia. Blood 140(Supplement 1), 2022. e-Pub 2022.
- Hernandez F, Guerrero A, Olivares S, Flores L, Najjar A, Singh H, Cooper L. ROR1-specific car for neuroblastoma using sleeping beauty-modified T cells. Journal of Clinical Oncology, 2018. e-Pub 2018.
- Hernandez F, DePombo A, Triche L, Quezada G, Rytting M. Neoadjuvant Anti-IL-6 Siltuximab improves resectability in Castleman disease: A case report. Pediatric Blood and Cancer, 2016. e-Pub 2016.
- Hernandez F, Triche L, Rytting M. Gemcitabine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma. British Journal of Haematology, 2015. e-Pub 2015.
- Cuglievan B, Hernandez F, De Angulo G, Vanni S, Graham R. Sirtuins and chemoresistance in Neuroblastoma. Pediatric Blood and Cancer, 2014. e-Pub 2014.
- Cuglievan B, Hernandez F, De Angulo G, Vanni S, Graham R. The role of NAMPT-NAD-Sirtuin pathway in neuroblastoma chemoresistance. Pediatric Blood and Cancer, 2014. e-Pub 2014.
- Hernandez F, De Angulo G, Vanni S, Graham R. Sirtuins as therapeutic targets for Neuroblastoma. Pediatric Blood and Cancer, 2013. e-Pub 2013.
- Hernandez F, Puerta N, De Angulo G, Vanni S, Graham R. Combined AKT and glycolysis inhibition for the treatment of Neuroblastoma. Pediatric Blood and Cancer, 2012. e-Pub 2012.
- Olivares S, Hernandez Fiorela, Zhang W, Gordon N, Gopalakrishnan V, Gill J, Gorlick R, Singh H. Ex vivo expanded tumor-infiltrating lymphocytes for sarcoma treatment. Connective Tissue Oncology Society Annual Meeting.
Book Chapters
- Hernandez Tejada, FN, Harrison, DJ. Neuroblastoma, 3125-3130.e1, 2024.
- Hernandez Tejada, FN, Herzog, CE. Neoplasms of the Liver, 3153-3156.e1, 2024.
- Hernandez Tejada FN, Herzog CE. Nelson Textbook of Pediatrics, 22nd Edition. Chapter 553 Neoplasms of the Liver.
- Hernandez Tejada FN, Harrison DJ. Nelson Textbook of Pediatrics, 22nd Edition. Chapter 547 Neuroblastoma.
Letters to the Editor
- Hernandez Tejada FN, Yedururi S, Kumar R, Stewart J, Tarek N. Ganglioneuroma with Disseminated Bone Lesions. Pediatric Blood and Cancer 64, 2017.
Patient Reviews
CV information above last modified September 08, 2026